Twist Bioscience Corp (TWST)
41.21
+9.20
(+28.74%)
USD |
NASDAQ |
May 03, 16:00
41.18
-0.03
(-0.07%)
After-Hours: 20:00
Twist Bioscience SG&A Expense (Quarterly): 55.62M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 55.62M |
December 31, 2023 | 52.84M |
September 30, 2023 | 47.39M |
June 30, 2023 | 46.06M |
March 31, 2023 | 53.96M |
December 31, 2022 | 42.32M |
September 30, 2022 | 54.16M |
June 30, 2022 | 53.69M |
March 31, 2022 | 54.00M |
December 31, 2021 | 51.10M |
September 30, 2021 | 38.24M |
June 30, 2021 | 34.48M |
March 31, 2021 | 34.39M |
December 31, 2020 | 28.79M |
Date | Value |
---|---|
September 30, 2020 | 27.18M |
June 30, 2020 | 22.49M |
March 31, 2020 | 27.19M |
December 31, 2019 | 26.40M |
September 30, 2019 | 24.42M |
June 30, 2019 | 21.32M |
March 31, 2019 | 19.12M |
December 31, 2018 | 15.26M |
September 30, 2018 | 12.95M |
June 30, 2018 | 11.26M |
March 31, 2018 | 9.978M |
December 31, 2017 | 9.263M |
September 30, 2017 | 8.409M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
21.32M
Minimum
Jun 2019
55.62M
Maximum
Mar 2024
39.80M
Average
40.28M
Median
SG&A Expense (Quarterly) Benchmarks
Tandem Diabetes Care Inc | 85.75M |
Perspective Therapeutics Inc | 1.694M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |